News & Publications

Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law. 

 

Written July 12, 2019

The US Patent and Trademark Office on July 10, 2019, designated as precedential Focal Therapeutics, Inc. v. SenoRx, Inc., Case IPR2014-00116 (PTAB July 21, 2014) (Paper 19). This order advises that, although counsel may not confer with a witness during cross-examination, counsel may confer with a witness after cross-examination has concluded and before redirect begins. This decision can be found on the PTAB Precedential and Informative Decisions page of the USPTO website.
Media Contact

Ariella Gordon

agordon@aipla.org

703-415-0780

 

 

Broadcast Opportunities

Looking for opportunities to get published? Submit your work to the AIPLA Quarterly Journal or AIPLA Innovate Magazine

 

 

Exhibitor and Sponsorship Opportunities

Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.

For rates, availability, or additional details, click here or contact:

Meghan Donohoe
COO
American Intellectual Property Law Association (AIPLA)
T| +1.703.415.1343
E| mdonohoe@aipla.org